Neuroimmune activation and chronic pain

AANA Journal

Volumn 79, Issue 1, 2011, Pages 31-37

  Griffis, Charles A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic pain; Neuroglia; Neuroimmune activation; Neuroinflammation

Indexed keywords

CHEMOKINE; EXCITATORY AMINO ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NITRIC OXIDE; OMEGA CONOTOXIN MVIIA; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANALGESIA; ARTICLE; CELL ACTIVATION; CELL THERAPY; CEREBROSPINAL FLUID; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME TYPE I; COMPLEX REGIONAL PAIN SYNDROME TYPE II; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GLIA CELL; HUMAN; HYPERALGESIA; NERVE CELL EXCITABILITY; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NONHUMAN;

CHRONIC DISEASE; HUMANS; NEUROIMMUNOMODULATION; NURSE ANESTHETISTS; PAIN;

EID: 79551595948     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. DeLeo JA, Tanga FY, Tawfik VL. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist. 2004;10(1):40-52.
2. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Back pain exacerbations and lost productive time costs in United States workers. Spine. 2006;31(26):3052-3060.
3. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum. 2005;53(5):673-681.
4. National Diabetes Information Clearinghouse. http://diabetes.niddk.nih.gov. Accessed July, 19, 2009.
5. Scadding JW, Koltzenburg M. Painful peripheral neuropathies. In: McMahon SB, Koltzenburg MK, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadephia, PA: Elsevier/Churchill Livingstone; 2006:973-999.
6. Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA. Lost productive time and costs due to diabetes and diabetic neuropathy pain in the US workforce. J Occup Environ Med. 2007;49(6):672-679.
7. Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Glia as the 'bad guys': implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immunol. 2007;21(2):131-146.
8. Watkins LR, Wiertelak EP, Goehler LE, et al. Neurocircuitry of illnessinduced hyperalgesia. Brain Res. 1994;639(2):283-299.
9. Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev. 2008;32(5):972-983.
10. Voorhies RM, Jiang X, Thomas N. Predicting outcome in the surgical treatment of lumbar radiculopathy using the Pain Drawing Score, McGill Short Form Pain Questionnaire, and risk factors including psychological issues and axial joint pain. Spine J. 2007;7(5):516-524.
11. Stoelting RK, Hillier SC. Pharmacology and Physiology in Anesthetic Practice. 4th ed. New York, NY: Lippincott Williams & Wilkins; 2006.
12. Saulino M, Burton AW, Danyo DA, Frost S, Glanzer J, Solanki DR. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports. Eur J Phys Rehabil Med. 2009;45(1):61-67.
13. Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine. 2005;30(1): 152-160.
14. Mayer DJ, Mao J, Holt J, Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA. 1999;96(14):7731-7736.
15. Watson CP, Chipman ML, Monks RC. Antidepressant analgesics: a systematic review and comparative study. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadephia, PA: Elsevier/Churchill Livingstone; 2006:481-497.
16. Sang CN, Hayes KS. Anticonvulsant medications in neuropathic pain. In: McMahon SB, Koltzenburg M, eds. Wall and Melzack's Textbook of Pain. 5th ed. Philadephia, PA: Elsevier/Churchill Livingstone; 2006: 499-506.
17. Garrison CJ, Dougherty PM, Carlton SM. GFAP expression in lumbar spinal cord of naïve and neuropathic rats treated with MK-801. Exp Neurol. 1994;129(2):237-243.
18. Garrison CJ, Doughterty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 1991;565 (1):1-7.
19. Lederboer A, Sloane EM, Milligan ED, et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005;115(1-2):71-83.
20. Lindia JA, McGowan E, Jochnowitz, N, Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain. 2005;6(7): 434-438.
21. Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology. 1994;33(11):1471-1478.
22. Chen SR, Samoriski G, Pan H. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain. Neuropharmacology. 2009;57 (2):121-126. (doi:10.1016/j.neuropharm.2009.04.010).
23. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82 (4):981-1011.
24. Koski CL. Humoral mechanisms in immune neuropathies. Neurol Clin. 1992;10(3):629-649.
25. Henry CJ, Huang Y, Wynne A, et al. Minocycline attenuates lipopoly -saccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. Neuroinflammation. 2008;5:15-28. (doi:10.1186/1742-2094-5-15).
26. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging. 2008;29(11):1744-1753.
27. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and system endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci. 2005;25(40):9275-9284.
28. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nature Rev. 2005;6(7):521-532.
29. Sloane E, Langer S, Jekich B, et al. Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. Gene Ther. 2009;16(10):1210-1222. (doi:10.1038/gt/20 09.79).
30. Milligan ED, Langer SJ, Sloane EM, et al. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci. 2005;21(8):2136-2148.
31. Messinger RB, Naik AK, Jagodic MM, et al. In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain. 2009;145(1-2):184-195. (doi:10.1016/j.pain2009.06.012).
32. Chiechio S, Zammataro M, Morales M. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol. 2009;75(5):1014-1020.
33. Backonja MM, Coe CL, Muller DA, Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol. 2008;195(1-2):157-163.
34. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116(3):213-219.
35. Jia H, Feng X, Li W, et al. Recombinant human erythropoietin attenuates spinal neuroimmune activation of neuropathic pain in rats. Ann Clin Lab Sci. 2009;39(1):84-91.
36. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective effect of recombinant human erythropoietin. Neurosci Lett. 2007;425(3):177-182.
37. Celik M, Gökmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA. 2002;99(4): 2258-2263.